Why the study?
Frailty significantly impacts heart failure outcomes, but there is no consensus on the optimal method for its assessment.
Integrating routine, multidimensional frailty assessments into clinical care is essential for optimizing treatment and improving outcomes in heart failure patients.
Incorporating frailty assessment may refine HF risk stratification; leaves open optimal tool standardization for trials.
PURPOSE OF REVIEW: This review aims to present the current state of the art in measuring frailty in patients with heart failure (HF), covering the entire spectrum from diagnosis to advanced stages of the disease. Frailty is a critical factor that significantly impacts outcomes in heart failure, and accurate assessment is essential for guiding treatment and improving prognosis. RECENT FINDINGS: Frailty is increasingly recognized as a key determinant of morbidity and mortality in HF patients. Various tools are available for assessing frailty, but there is no consensus on the optimal method. The assessment of frailty needs to be multidimensional, incorporating physical, cognitive, and social domains. Early detection of frailty, coupled with personalized interventions, has the potential to improve patient outcomes. Integrating routine frailty assessments into the clinical care of heart failure patients is essential for optimizing treatment. Future research should focus on standardizing frailty assessment tools and integrating innovative technologies, such as artificial intelligence, to enhance the precision and applicability of these assessments in clinical practice.
No takes yet. Share an insight, caveat, or question.
Uchmanowicz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: